Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers

BACKGROUND AND AIMS: COVID-19 is already a pandemic. Emerging data suggest an increased association and a heightened mortality in patients of COVID-19 with comorbidities. We aimed to evaluate the outcome in hypertensive patients with COVID-19 and its relation to the use of renin-angiotensin system b...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Awadhesh Kumar, Gupta, Ritesh, Misra, Anoop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144598/
https://www.ncbi.nlm.nih.gov/pubmed/32283499
http://dx.doi.org/10.1016/j.dsx.2020.03.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144598/
https://www.ncbi.nlm.nih.gov/pubmed/32283499
http://dx.doi.org/10.1016/j.dsx.2020.03.016

Ejemplares similares